This round is no longer accepting investments, but others just like it are live now.

CLOSED

GET A PIECE OF APERIO BEAUTY

Personalized Anti-Aging Skincare Solutions

Aperio Beauty offers a new kind of skincare. Using proven science and plant-based ingredients, our skincare platform enables customers to target their specific skin-aging factors by assessing each person’s unique DNA “fingerprint” and pairing them with personalized products that have proven effective results.

Show more

This Reg CF offering is made available through StartEngine Capital, LLC. This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment.
Company Image

REASONS TO INVEST

Reasons Icon

Aperio Beauty’s platform design fulfills a large unmet need in the premium anti-aging skincare segment, with each serum addressing all categories of aging as a streamlined one-stop solution, driven by deep penetrating, safe, and highly effective plant-based ingredients.

Reasons Icon

In January 2022, Aperio Beauty was accepted onto Live Love Spa’s distribution platform. Live Love Spa is the pre-eminent premium skincare distributor that partners exclusively with premier skincare brands that meet their stringent selection criteria - focusing on the quality, safety, and effectiveness of ingredients, in addition to the most advanced, unique ingredient technology.

Reasons Icon

The anti-aging market, which was valued at $194.4 billion in 2020, is expected to grow at an 8.6% CAGR from 2021 to 2030.*

TEAM

Ali Radfar

Ali Radfar • CEO, CSO, and Director

Prior to Aperio, Dr. Radfar was Co-Founder and CEO of Neolitics, a revenue stage spectroscopy company offering analytic solutions across the chemical / petrochemical, food and beverage, and pharmaceutical sectors.

Prior to Neolitics, Dr. Radfar was a co-founder of the International Federation of Adipose Therapeutics and Science, a non-profit organization focused on adipose-derived stem cells, and their application towards tissue regeneration and therapeutics. 

He holds an M.D. from the University of Pittsburgh School of Medicine. During his medical school training, Ali spent 2 years working as a molecular genetics research associate, with a focus on applying novel gene therapy vehicles towards effecting scarless wound healing, in the context of both clinical medicine as well as aesthetics. It was through this experience, that he developed a keen appreciation of molecular genetics, as it may be applied towards the healing of skin and complex supporting skin structures. Dr. Radfar is also a Phi Beta Kappa honors graduate of John Hopkins University, having earned a Bachelor of Arts degree in Molecular Cell Biology.

Read More

Andrew Terry Rosenbaum

Andrew Terry Rosenbaum • CFO, COO, and Director

Prior to Aperio Beauty, Terry has been a professional in the financial services industry for 5+ years, advising clients in the biopharma, life sciences, and diagnostics spaces, on strategic alternatives. He most recently worked at Perella Weinberg Partners as an Associate in their San Francisco office. Terry holds a B.S. degree in Finance and Marketing from New York University’s Leonard N. Stern School of Business.

Read More

Gloria Story Dittus

Gloria Story Dittus • Director

Gloria is the Founder of Story Partners, a premier public affairs and public relations firm, with expertise in complex communications on behalf of government, technology, healthcare, energy and transportation organizations. Gloria and past / current businesses have provided transformative guidance on managing national disasters and pandemics, including the resurrection of New Orleans following Hurricane Katrina, as well as providing complex organizational guidance to the U.S. Government in the presence of the COVID-19 pandemic. Gloria brings to Aperio a global network of strategic contacts in the Wellness and Luxury Products segments.

Read More

*Market statistics provided by P&S Intelligence (source)

Anti-Aging Tailored to Your Unique DNA Profile

At Aperio Beauty, we investigate the genetics behind skin health and aging, using extensive research to guide our careful selection of safe, natural ingredients that provide a positive impact across all six categories of aging.



Aperio Beauty seeks to bring the modern era of genomics to the realm of the daily anti-aging consumer routine. The science we employ is proven and its utility is available to meet a significant unmet need which continues to exist in rejuvenation products. While this cutting-edge science has been available for nearly two decades, it is only now being applied in a cosmetic approach.



Everything begins with our Complete Base Serum, the core serum upon which each of our six Category-Specific Serums is derived. 



On top of our Complete Base Serum, each of our Category-Specific Serums includes an additional subset of the most powerful ingredients to provide an increased impact to their respective aging category.


Our Traction


A Primed Platform and Powerful Partnerships

With just over $1.2 Million raised, Aperio Beauty has achieved the following milestones:


  • Developed a proprietary DNA primer that identifies 105 DNA variations tied to premature aging.
  • Developed 7 different serums (our Complete Base Serum and six Category-Specific Serums) that are in commercial form and generating revenue.
  • Developed a genetic marker and ingredients database, replete with over 125 target-specific and mechanistically-acting ingredients, to drive the launch of numerous products.
  • Launched with 20 distribution partners since a majority of the United States began re-opening post-COVID - including, most importantly, Live Love Spa.



We were accepted on to Live Love Spa’s distribution platform in January 2022.  Live Love Spa is the pre-eminent premium skincare distributor that partners exclusively with premiere skincare brands that meet their stringent selection criteria - focusing on the quality, safety and effectiveness of ingredients, in addition to the most advanced, unique ingredient technology.


Partnering with Live Love Spa is coveted and highly regarded in the industry, providing Aperio access to a singular platform with access to premiere spas, medical spas (“MediSpas”), destination resorts, and estheticians. Live Love Spa’s platform provides access to over 20,000 unique locations, and our products will immediately be showcased on the Live Love Spa website, spafinder.com. Live Love Spa’s additional client base includes The Four Seasons, Hyatt (including Waldorf Astoria), Rosewood Resorts, Hilton, as well as many chain spas, each with a minimum of 40 plus locations.


Source: Live Love Spa


Live Love Spa also hosts events that allow further streamlined networking capabilities along with pertinent relationship building. These events take place nationwide and each have decision-makers from 40+ spa brands - we will have complete access to attend these events as desired. We will also be included in Live Love Spa’s exclusive "Discovery Box" marketing platform – where clients included in this offering are exposed to decision-makers at the top resorts worldwide, with anywhere from 150-600 locations. The box will include a full size Aperio Complete Base Serum along with detailed information for decision-makers at the resorts.


Based on the number of distribution channels and the clientele list of Live Love Spa’s platform, Aperio will have a massive opportunity, independent for the otherwise requisite requirement of a large sales team.


Live Love Spa provides to Aperio Beauty each of the following channels of distribution:

  • Wholesale to other spas, resorts, estheticians and MediSpas
  • Direct-to-consumer based sales through the e-commerce capabilities of Live Love Spa directly and spafinder.com. Live Love Spa is also in the process of offering their e-commerce capabilities to these premiere hotel chains, which will provide direct-to-consumer sales potential with the premiere hotel chains’ high-end clientele.
  • Retail sales through hotel partnerships that run back through the Live Love Spa platform


From a list of 20,000 potential elite spa locations within the Live Love Spa network, Aperio believes that penetrating less than 1% of these (i.e., potentially 200 locations at steady-state), provides significant opportunity for scale and growth. The visibility of a brand on these platforms is enormous and the potential for growth is exponential.

The Problem


We Believe the Current Skincare Industry Lacks Innovation

The science surrounding skincare has advanced tremendously over the past decade, but we believe skincare companies have failed to invest in product innovation.  


With the rise of e-commerce, the skincare industry tends to focus most of their investment into their brand and marketing as opposed to the effectiveness and quality of their products. This leaves customers with too many options and complicated regimens, requiring a large time commitment to research and understand their unique skincare needs.


Similarly, spas and MediSpas must carry many different branded skincare products for retail and do not have access to a singular product that can be paired with their service offerings (i.e., facials, micro-needling, etc.).


The Solution


A Genomics-Driven, Personalized Anti-Aging Platform

We believe that Aperio Beauty is the first beauty-tech company to provide both a high-resolution anti-aging DNA panel and a personalized serum solution.


Based on their unique DNA profile, we pair customers with one of our six Category-Specific Serums personalized to match their aging category of greatest need.



This is why our platform fulfills a large unmet need in the anti-aging skincare market, providing a simple one-stop shop solution that addresses every target of aging without the need for expensive and time-consuming skincare regimens.



Aperio is primarily B2B, working with MediSpas and resorts where we take our six Category-Specific Serums and bundle them into actual spa-based procedures. We offer our distribution partners two partnership options - consignment and traditional wholesale.


Customers look to their dermatologists, plastic surgeons, and estheticians for an expert opinion on what skincare products to use. As our list of MediSpa partners grows, we expect to see continued success in this area. Additionally, a portion of the proceeds from this raise will be directed toward online marketing to continue to improve Aperio Beauty’s brand awareness outside of these environments.



The Market


Anti-Aging Products are in High Demand

In 2020, the anti-aging market was valued at $194.4 billion in 2020 and is expected to grow at an 8.6% CAGR from 2021 to 2030 (source). Further demonstrating this growth, according to the United Nations Department of Economic and Social Affairs, the share of the global population of individuals aged 65 years and above is expected to increase from 9.3% in 2020 to 16.0% in 2050 (source).


With the power of our genetics and ingredients database, we believe Aperio will continue to grow our share of the overall anti-aging market. The competitive advantages of our products set us apart from other premium skincare lines.



The singular nature of Aperio Beauty’s platform and powerful anti-aging serums cover many needs for MediSpas and skincare customers that aren’t currently addressed - and the innovation of our products is already proving out within MediSpas.


MediSpas traditionally generates sales in two segments: Services and Retail Products. This creates a confusing and disjointed system for customers who want a simple skincare solution. So how are we filling in the gap?


Why Invest


Ready to Revolutionize Skincare

Aperio Beauty is offering a new kind of skincare, and with the milestones we've reached thus far, we believe we're helping create a bright future for the industry.


Our current complete genetic marker and ingredients database will drive the development and commercialization of numerous additional products, including:



Our core platform knowledge, which focuses on blocking inflammation and free radicals and healing skin through plant-derived growth factors, will continue to be key in the design and launch of our products, creating a healthy environment in the above areas of treatment.


We want to revolutionize skincare - and we hope you'll join us in doing so.


Look to your unique DNA to embrace the future of personalized beauty…

Unlock Your Natural Beauty!

ABOUT

HEADQUARTERS
3165 Sawtelle Blvd, #214
Los Angeles, CA 90066
WEBSITE
View Site
Aperio Beauty offers a new kind of skincare. Using proven science and plant-based ingredients, our skincare platform enables customers to target their specific skin-aging factors by assessing each person’s unique DNA “fingerprint” and pairing them with personalized products that have proven effective results.

TERMS

Aperio Beauty
Overview
PRICE PER SHARE
$1.25
DEADLINE
Sep. 10, 2022 at 6:59 AM UTC
VALUATION
$11.3M
FUNDING GOAL
$10K - $1.07M
Breakdown
MIN INVESTMENT
$100
MAX INVESTMENT
$1,070,000
MIN NUMBER OF SHARES OFFERED
8,000
MAX NUMBER OF SHARES OFFERED
856,000
OFFERING TYPE
Equity
SHARES OFFERED
Common Stock

Maximum Number of Shares Offered subject to adjustment for bonus shares

Voting Rights of Securities Sold in this Offering

Voting Proxy. Each Subscriber shall appoint the Chief Executive Officer of the Company (the “CEO”), or his or her successor, as the Subscriber’s true and lawful proxy and attorney, with the power to act alone and with full power of substitution, to, consistent with this instrument and on behalf of the Subscriber, (i) vote all Securities, (ii) give and receive notices and communications, (iii) execute any instrument or document that the CEO determines is necessary or appropriate in the exercise of its authority under this instrument, and (iv) take all actions necessary or appropriate in the judgment of the CEO for the accomplishment of the foregoing. The proxy and power granted by the Subscriber pursuant to this Section are coupled with an interest. Such proxy and power will be irrevocable. The proxy and power, so long as the Subscriber is an individual, will survive the death, incompetency and disability of the Subscriber and, so long as the Subscriber is an entity, will survive the merger or reorganization of the Subscriber or any other entity holding the Securities. However, the Proxy will terminate upon the closing of a firm-commitment underwritten public offering pursuant to an effective registration statement under the Securities Act of 1933 covering the offer and sale of Common Stock or the effectiveness of a registration statement under the Securities Exchange Act of 1934 covering the Common Stock.

Investment Incentives and Bonuses*

Time-Based Perks:

  • Invest during the first week, and receive 20% bonus shares.
  • Invest during the second week, and receive 15% bonus shares.
  • Invest during the third week, and receive 10% bonus shares.
  • Invest during the fourth week, and receive 5% bonus shares.

Amount-Based Perks:

  • Tier 1 Perk ($500 - $999 invested):
    • Receive a 15% discount on all future purchases.
  • Tier 2 Perk ($1,000 - $2,499 invested):
    • Receive a 20% discount on all future purchases.
    • Receive 10 mL of Complete Base Serum.
  • Tier 3 perk ($2,500 - $4,999 invested):
    • Receive a 25% discount on all future purchases and two 10 mL of Complete Base Serum. 
    • Call with one of the Founders of Aperio Beauty:
      • Dr. Ali Radfar - CEO and CSO / Creator of Aperio Beauty Platform and Serums
      • Terry Rosenbaum - CFO and COO
  • Tier 4 perk ($5,000 - $9,999 invested):
    • Receive a 30% discount on all future purchases.
    • Receive a 30 mL of Complete Base Serum.
    • Call with Core Aperio Beauty Management Team:
      • Dr. Ali Radfar - CEO and CSO / Creator of Aperio Beauty Platform and Serums
      • Terry Rosenbaum - CFO and COO
  • Tier 5 perk ($10,000 - $24,999 invested):
    • Receive 5% bonus shares.
    • Receive a 30% discount on all future purchases.
    • Receive 50 mL of Complete Base Serum.
    • Call with Core Aperio Beauty Management Team:
      • Dr. Ali Radfar - CEO and CSO / Creator of Aperio Beauty Platform and Serums
      • Terry Rosenbaum - CFO and COO
  • Tier 6 perk - ($25,000 - $49,999 invested):
    • Receive 10% bonus shares.
    • Receive a 30% discount on all future purchases.
    • Receive a complimentary DNA-based Saliva Test.
    • Receive a 30 mL of Complete Base Serum (comes with Test)
    • Receive a 50 mL of one of Aperio Beauty's 6 Category-Specific Serums personalized for you (guided by saliva-based DNA test), received 4 weeks after mail-in of test in a pre-paid UPS envelope.
    • Call with Aperio Founders Dr. Ali Radfar or Terry Rosenbaum to explain the DNA test and process
    • Call 4 weeks post-DNA Test for results, along with customized DNA Output Report
    • Call with Core Aperio Beauty Management Team:
      • Dr. Ali Radfar - CEO and CSO / Creator of Aperio Beauty Platform and Serums
      • Terry Rosenbaum - CFO and COO
  • Tier 7 perk - ($50,000+ invested):
    • Receive 15% bonus shares.
    • Receive a 35% discount on all future purchases.
    • Receive a complimentary DNA-based Saliva Test.
    • Receive a 30 mL of Complete Base Serum (comes with Test).
    • Receive a 50 mL of one of Aperio Beauty's 6 Category-Specific Serums personalized for you (guided by Saliva-based DNA test), received 4 weeks after mail-in of Test in a pre-paid UPS envelope.
    • Call with Aperio Founders Dr. Ali Radfar or Terry Rosenbaum to explain the DNA test and process.
    • Call 4 weeks post-DNA Test for Results, along with customized DNA Output Report.
    • Call with Core Aperio Beauty Management Team:
      • Dr. Ali Radfar - CEO and CSO / Creator of Aperio Beauty Platform and Serums
      • Terry Rosenbaum - CFO and COO

*All perks occur when the offering is complete.

The 10% StartEngine Owners' Bonus

Aperio Genetics Inc. (d/b/a Aperio Beauty) will offer 10% additional bonus shares for all investments that are committed by investors that are eligible for the StartEngine Crowdfunding Inc. OWNer's bonus.

This means eligible StartEngine shareholders will receive a 10% bonus for any shares they purchase in this offering. For example, if you buy 100 shares of Common Stock at $1.25 / share, you will receive 110 shares of Common Stock, meaning you'll own 110 shares for $125. Fractional shares will not be distributed and share bonuses will be determined by rounding down to the nearest whole share.

This 10% Bonus is only valid during the investors' eligibility period. Investors eligible for this bonus will also have priority if they are on a waitlist to invest and the company surpasses its maximum funding goal. They will have the first opportunity to invest should room in the offering become available if prior investments are canceled or fail.

Investors will receive the highest single bonus they are eligible for among the bonuses based on the amount invested and the time of offering elapsed (if any). Eligible investors will also receive the Owner’s Bonus in addition to the aforementioned bonus.

Irregular Use of Proceeds

The Company might incur Irregular Use of Proceeds that may include but are not limited to the following over $10,000: Vendor payments.

ALL UPDATES

09.08.22

Company Presentation at Industry Event – The Florida Academy of Medical Aesthetics

Hello Everyone!

 

We are excited to announce that we will be a Platinum Sponsor of The Florida Academy of Medical Aesthetics' (FAMA) Graduation Expo, to be held October 2, 2022, in Pembroke Pines, Florida.  The Academy’s focus is on training entrepreneurial estheticians, who may progress upon graduation to opening up their own spa or medical spa business.

A picture containing text, sky, road, outdoor

Description automatically generated

This year’s event will include 200 recent graduates from the period 2020 to 2022, 70% of whom currently operate their own spas.  As part of Aperio’s sponsorship, we will:

 

  • Have our brand materials on all event displays and attendee information packets
  • Provide a 7-minute podium-based presentation to the graduate audience
  • Engage individually with each of the graduates / spa owners during a 4-hour period
  • Receive contact information for the extended audience

 

We are confident that the event will lead to numerous new spa-based accounts, through which to grow our business pipeline and brand awareness.

 

As we near our campaign’s close, we wanted to thank you all again for being a part in helping us achieve our dreams.

 

All the best,

 

Ali Radfar, M.D.

 

CEO and Founder of Aperio Beauty

08.10.22

Notice of Material Change in Offering

[The following is an automated notice from the StartEngine team].

Hello! Recently, a change was made to the Aperio Beauty offering. Here's an excerpt describing the specifics of the change:


Issuer is extending campaign end date and updating team.


When live offerings undergo changes like these on StartEngine, the SEC requires that certain investments be reconfirmed. If your investment requires reconfirmation, you will be contacted by StartEngine via email with further instructions.

07.26.22

Our Community Joins In! | Insider Investment Notice

We’re excited to see our community come in and invest in Aperio Beauty!

Our Insiders have invested a total of $38,295.00 into the offering.

We hope you join and invest in Aperio Beauty as well!

Please refer to the Company’s offering materials for further information and refer to the Company’s Risk Factors.

06.15.22

Launch with New Distribution Partner – The Skin Center at Benton Integrative Medicine

Hello Everyone!

Aperio Beauty is delighted to announce the launch of our newest distribution partnership with Benton Integrative Medicine / The Skin Center at Benton Integrative Medicine, with 3 locations in Huntersville, Charlotte and Denver, North Carolina.  Led by Cammy Benton-Espinosa, M.D. and Tammy Ryan, MSN, the Benton team espouses a holistic integrative medicine approach to improve the health of their clients, inclusive of the most modern aesthetics platforms and services, with a focus on plant-derived skincare products.

For those of you who have invested, thank you!  Your support has shown - spread the word of this campaign, share it with your friends and family – remember, our success is your success!

For those of you who have not yet finished your investment, our campaign’s time-based perks will be expiring in one week.  We want you to join our ever-growing family (now over $52,500 in committed funds raised) as Aperio Beauty brings DNA-based personalized skincare to the market.

We will continue to keep you updated as we continue to progress.  Thank you all again for being a part in helping us achieve our dreams.

We Wish You All the Best,

Ali Radfar, M.D.

Founder and CEO, Aperio Beauty

06.08.22

Launch with New Distribution Partner – Nigel Beauty Emporium

Hello Everyone!

We are so pleased to announce the launch of Aperio Beauty’s newest distribution partnership with Nigel Beauty Emporium, located in North Hollywood, CA.  With a space spreading over 7,000 square feet, Nigel’s is dedicated to showcasing the very best of beauty the world has to offer.  Since it’s founding in 2007, Nigel Beauty Emporium boasts an executive team with over 77 years of combined professional experience in supplying Hollywood’s most discerning clientele, notably actresses, producers and various other celebrity figures.  Alongside top makeup artists, hairstylists and bloggers that feature Nigel and a variety of products, Nigel Beauty Emporium has been featured in numerous consumer and industry publications.

For those of you who have invested, thank you!  Your support has shown - Spread the word of this campaign, share it with your friends and family – remember, our success is your success!

For those of you who have not yet finished your investment, our campaign’s time-based perks will be expiring in one week.  We want you to join our ever-growing family (now over $52,000 in committed funds raised) as Aperio Beauty brings DNA-based personalized skincare to the market.

We will continue to keep you updated as we continue to progress.  Thank you all again for being a part in helping us achieve our dreams.

We Wish You All the Best,

Ali Radfar, M.D.

Founder and CEO, Aperio Beauty

05.31.22

Launch with New Distribution Partner – True Face and Body

Hello Everyone!

We are delighted to announce the launch of another distribution partnership with True Face and Body, an eco-focused, organic spa, offering tailored skincare services with nature-delivered skincare benefits.  Led by Patti Coughlin, a certified massage therapist and exercise physiologist (Master’s Degree, UCLA), True Face and Body has built a loyal customer following who demand a nature-driven path to holistic health and skincare.

 

For those of you who have invested, thank you!  Your support has shown Spread the word of this campaign, share it with your friends and family – remember, our success is your success!

For those of you who have not yet finished your investment, our campaign’s time-based perks will be expiring in two weeks.  We want you to join our ever-growing family (now over $51,000 in committed funds raised) as Aperio Beauty brings DNA-based personalized skincare to the market.

We will continue to keep you updated as we continue to progress.  Thank you all again for being a part in helping us achieve our dreams.


All the best,

Ali Radfar, M.D.

CEO and Founder of Aperio Beauty

05.27.22

Launch with New Distribution Partner – Naturally Bare Skincare

Hello Everyone!

We are delighted to announce the launch of a distribution partnership with Naturally Bare, a specialty spa focusing exclusively on the application of the most technologically-advanced plant delivery-enabled skincare services and product offerings.  Led by Deirdre Gavin, an experienced medical assistant, formulator and skincare educator, Naturally Bare Skincare’s team specializes in tailoring any given service to a customer’s individual needs – with a focus on product safety and efficacy.  Naturally Bare has a focus on fulfilling improvements in customer skin firmness and skin texture and tone improvements, and as such Aperio Beauty serums are ideally positioned for this valuable partnership.

 

For those of you who have invested, thank you!  Your support has shown Spread the word of this campaign, share it with your friends and family – remember, our success is your success!

For those of you who have not yet finished your investment, our campaign’s time-based perks will be expiring in two weeks.  We want you to join our ever-growing family (now over $50,000 in committed funds raised) as Aperio Beauty brings DNA-based personalized skincare to the market.

We will continue to keep you updated as we continue to launch with new distribution partners.  Thank you all again for being a part in helping us achieve our dreams.


All the best,

Ali Radfar, M.D.

CEO and Founder of Aperio Beauty

REWARDS

Multiple investments in an offering cannot be combined to qualify for a larger campaign reward.

10%

Stack Venture Club & Rewards!

Members get an extra 10% shares in addition to rewards below!

Venture Club

Venture Club

Venture Club Members earn 10% bonus shares on top of this and all eligible investments for an entire year. Not a member? Sign up at checkout ($275/year).

$500

Tier 1 Perk ($500 - $999 invested)

Receive a 15% discount on all future purchases.

$1,000

Tier 2 Perk ($1,000 - $2,499 invested)

Receive a 20% discount on all future purchases. Receive 10 mL of Complete Base Serum.

$2,500

Tier 3 perk ($2,500 - $4,999 invested)

Receive a 25% discount on all future purchases and two 10 mL of Complete Base Serum. Call with one of the Founders of Aperio Beauty: Dr. Ali Radfar - CEO and CSO / Creator of Aperio Beauty Platform and Serums Terry Rosenbaum - CFO and COO

$5,000

Tier 4 perk ($5,000 - $9,999 invested)

Receive a 30% discount on all future purchases. Receive a 30 mL of Complete Base Serum. Call with Core Aperio Beauty Management Team: Dr. Ali Radfar - CEO and CSO / Creator Terry Rosenbaum - CFO and COO

$10,000

Tier 5 perk ($10,000 - $24,999 invested)

Receive 5% bonus shares. Receive a 30% discount on all future purchases. Receive 50 mL of Complete Base Serum. Call with Core Aperio Beauty Management Team: Dr. Ali Radfar - CEO and CSO Terry Rosenbaum - CFO and COO

$25,000

Tier 6 perk - ($25,000 - $49,999 invested):

Receive 10% bonus shares, 30% discount on all future purchases, DNA-based Saliva Test, 30 mL of Complete Base Serum, 50 mL of one of Aperio Beauty's 6 Category-Specific Serums, calls with Aperio Founders & Management Team, and call post-DNA Test...

$50,000

Tier 7 perk - ($50,000+ invested)

Receive 15% bonus shares, 35% discount on all future purchases, DNA-based Saliva Test, 30 mL of Complete Base Serum, 50 mL of one of Aperio Beauty's 6 Category-Specific Serums, calls with Aperio Founders & Management Team, and call post-DNA Test...

JOIN THE DISCUSSION

0/2500

DR
David Ren

3 years ago

Any updates on financing?

0

0

IV
Isaac Villanueva

3 years ago

Product features

0

0

HOW INVESTING WORKS

Cancel anytime before 48 hours before a rolling close or the offering end date.

FAQ Timeline

WHY STARTENGINE?

Rewards Icon
REWARDS

We want you to succeed and get the most out of your money by offering rewards and memberships!

Lock Icon
SECURE

Your info is your info. We take pride in keeping it that way!

Ellipse Icon
DIVERSE INVESTMENTS

Invest in over 200 start-ups and collectibles!

FAQS

With Regulation A+, a non-accredited investor can only invest a maximum of 10% of their annual income or 10% of their net worth per year, whichever is greater. There are no restrictions for accredited investors.

With Regulation Crowdfunding, non-accredited investors with an annual income or net worth less than $124,000 are limited to invest a maximum of 5% of the greater of those two amounts. For those with an annual income and net worth greater than $124,000, they are limited to investing 10% of the greater of the two amounts.

At the close of an offering, all investors whose funds have “cleared” by this time will be included in the disbursement. At this time, each investor will receive an email from StartEngine with their Countersigned Subscription Agreement, which will serve as their proof of purchase moving forward.

Please keep in mind that a company can conduct a series of “closes” or withdrawals of funds throughout the duration of the campaign. If you are included in that withdrawal period, you will be emailed your countersigned subscription agreement and proof of purchase immediately following that withdrawal.

StartEngine assists companies in raising capital, and once the offering is closed, we are no longer involved with whether the company chooses to list shares on a secondary market or what occurs thereafter. Therefore, StartEngine has no control or insight into your investment after the close of the live offering. In addition, we are not permitted to provide financial advice. You may want to contact a financial professional to discuss possible investment outcomes.

For Regulation Crowdfunding, investors are able to cancel their investment at any point throughout the campaign up until 48 hours before the closing of the offering. Note: If the company does a rolling close, they will post an update to their current investors, giving them the opportunity to cancel during this timeframe. If you do not cancel within this 5-day timeframe, your funds will be invested in the company, and you will no longer be able to cancel the investment. If your funds show as ‘Invested’ on your account dashboard, your investment can no longer be canceled.

For Regulation A+, StartEngine allows for a four-hour cancellation period. Once the four-hour window has passed, it is up to each company to set their own cancellation policy. You may find the company’s cancellation policy in the company’s offering circular.

Once your investment is canceled, there is a 10-day clearing period (from the date your investment was submitted). After your funds have cleared the bank, you will receive your refund within 10 business days.

Refunds that are made through ACH payments can take up to 10 business days to clear. Unfortunately, we are at the mercy of the bank, but we will do everything we can to get you your refund as soon as possible. However, every investment needs to go through the clearing process in order to be sent back to the account associated with the investment.

Both Title III (Regulation Crowdfunding) and Title IV (Reg A+) help entrepreneurs crowdfund capital investments from unaccredited and accredited investors. The differences between these regulations are related to the investor limitations, the differing amounts of money companies are permitted to raise, and differing disclosure and filing requirements. To learn more about Regulation Crowdfunding, click here, and for Regulation A+, click here.

MIN INVEST
$100
VALUATION
$11.3M

Important Message

IN MAKING AN INVESTMENT DECISION, INVESTORS MUST RELY ON THEIR OWN EXAMINATION OF THE ISSUER AND THE TERMS OF THE OFFERING, INCLUDING THE MERITS AND RISKS INVOLVED. INVESTMENTS ON STARTENGINE ARE SPECULATIVE, ILLIQUID, AND INVOLVE A HIGH DEGREE OF RISK, INCLUDING THE POSSIBLE LOSS OF YOUR ENTIRE INVESTMENT.

www.StartEngine.com is a website owned and operated by StartEngine Crowdfunding, Inc. (“StartEngine”), which is neither a registered broker-dealer, investment advisor nor funding portal.

Unless indicated otherwise with respect to a particular issuer, all securities-related activity is conducted by regulated affiliates of StartEngine: StartEngine Capital LLC, a funding portal registered here with the US Securities and Exchange Commission (SEC) and here as a member of the Financial Industry Regulatory Authority (FINRA), or StartEngine Primary LLC (“SE Primary”), a broker-dealer registered with the SEC and FINRA / SIPC. You can review the background of our broker-dealer and our investment professionals on FINRA’s BrokerCheck here. StartEngine Secondary is an alternative trading system (ATS) regulated by the SEC and operated by SE Primary. SE Primary is a member of SIPC and explanatory brochures are available upon request by contacting SIPC at (202) 371-8300.

StartEngine facilitates three types of primary offerings:

1) Regulation A offerings (JOBS Act Title IV; known as Regulation A+), which are offered to non-accredited and accredited investors alike. These offerings are made through StartEngine Primary, LLC (unless otherwise indicated). 2) Regulation D offerings (Rule 506(c)), which are offered only to accredited investors. These offerings are made through StartEngine Primary, LLC. 3) Regulation Crowdfunding offerings (JOBS Act Title III), which are offered to non-accredited and accredited investors alike. These offerings are made through StartEngine Capital, LLC. Some of these offerings are open to the general public, however there are important differences and risks.

Any securities offered on this website have not been recommended or approved by any federal or state securities commission or regulatory authority. StartEngine and its affiliates do not provide any investment advice or recommendation and do not provide any legal or tax advice concerning any securities. All securities listed on this site are being offered by, and all information included on this site is the responsibility of, the applicable issuer of such securities. StartEngine does not verify the adequacy, accuracy, or completeness of any information. Neither StartEngine nor any of its officers, directors, agents, and employees makes any warranty, express or implied, of any kind whatsoever related to the adequacy, accuracy, or completeness of any information on this site or the use of information on this site.

Investing in private company securities is not suitable for all investors. An investment in private company securities is highly speculative and involves a high degree of risk. It should only be considered a long-term investment. You must be prepared to withstand a total loss of your investment. Private company securities are also highly illiquid, and there is no guarantee that a market will develop for such securities. Each investment also carries its own specific risks, and you should complete your own independent due diligence regarding the investment. This includes obtaining additional information about the company, opinions, financial projections, and legal or other investment advice. Accordingly, investing in private company securities is appropriate only for those investors who can tolerate a high degree of risk and do not require a liquid investment. See additional general disclosures here.

By accessing this site and any pages on this site, you agree to be bound by our Terms of use and Privacy Policy, as may be amended from time to time without notice or liability.

Canadian Investors

Investment opportunities posted and accessible through the site will not be offered to Canadian resident investors. Potential investors are strongly advised to consult their legal, tax and financial advisors before investing. The securities offered on this site are not offered in jurisdictions where public solicitation for offerings is not permitted; it is solely your responsibility to comply with the laws and regulations of your country of residence.

California Investors Only – Do Not Sell My Personal Information (800-317-2200). StartEngine does not sell personal information. For all customer inquiries, please write to contact@startengine.com.

StartEngine Marketplace (“SE Marketplace”) is a website operated by StartEngine Primary, LLC (“SE Primary”), a broker-dealer that is registered with the SEC and a member of FINRA and the SIPC.

StartEngine Secondary (“SE Secondary”) is our investor trading platform. SE Secondary is an SEC-registered Alternative Trading System (“ATS”) operated by SE Primary that matches orders for buyers and sellers of securities. It allows investors to trade shares purchased through Regulation A+, Regulation Crowdfunding, or Regulation D for companies who have engaged StartEngine Secure LLC as their transfer agent. The term “Rapid,” when used in relation to transactions on SE Marketplace, specifically refers to transactions that are facilitated on SE Secondary, This is because, unlike with trades on the StartEngine Bulletin Board (“SE BB”), trades on SE Secondary are executed the moment that they are matched.

StartEngine Bulletin Board (“SE BB”) is a bulletin board platform on which users can indicate to each other their interest to buy or sell shares of private companies that previously executed Reg CF or Reg A offerings not necessarily through SE Primary. As a bulletin board platform, SE BB provides a venue for investors to access information about such private company offerings and connect with potential sellers. All investment opportunities on SE BB are based on indicated interest from sellers and will need to be confirmed. Even if parties express mutual interest to enter into a trade on SE BB, a trade will not immediately result because execution is subject to additional contingencies, including among others, effecting of the transfer of the shares from the potential seller to the potential buyer by the issuer and/or transfer agent. SE BB is distinct and separate from SE Secondary. SE Secondary facilitates the trading of securities by matching orders between buyers and sellers and facilitating executions of trades on the platform. By contrast, under SE BB, SE Primary assists with the facilitation of a potential resulting trade off platform including, by among other things, approaching the issuer and other necessary parties in relation to the potential transaction. The term “Extended”, when used in relation to transactions on SE Marketplace denotes that these transactions are conducted via SE BB, and that these transactions may involve longer processing times compared to SE Secondary for the above-stated reasons.

Even if a security is qualified to be displayed on SE Marketplace, there is no guarantee an active trading market for the securities will ever develop, or if developed, be maintained. You should assume that you may not be able to liquidate your investment for some time or be able to pledge these shares as collateral.

The availability of company information does not indicate that the company has endorsed, supports, or otherwise participates with StartEngine. It also does not constitute an endorsement, solicitation or recommendation by StartEngine. StartEngine does not (1) make any recommendations or otherwise advise on the merits or advisability of a particular investment or transaction, (2) assist in the determination of the fair value of any security or investment, or (3) provide legal, tax, or transactional advisory services.